3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Peripheral Blood Stem Cell Transplantation
38
fludarabine phosphate
34
Cyclophosphamide
30
Mycophenolic Acid
25
Whole-Body Irradiation
22
Cyclosporine
22
Tacrolimus
21
Busulfan
18
Methotrexate
17
Antilymphocyte Serum
16
Radiotherapy
14
Flow Cytometry
13
Filgrastim
13
Etoposide
13
Vorinostat
10
Methylprednisolone
10
Bortezomib
10
Bexarotene
10
Melphalan
9
Therapeutics
8
Rituximab
8
Psychiatric Rehabilitation
8
Polymerase Chain Reaction
8
Lenalidomide
8
Gemcitabine
8
romidepsin
7
fludarabine
6
Cord Blood Stem Cell Transplantation
6
Brentuximab Vedotin
6
tanespimycin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
resminostat
×
Dermatologic
×
Clear all
NCT02953301
2024-08-30
RESMAIN
4SC AG
Phase 2
Completed
201 enrolled